Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer - Wolff, AC; Lazar, AA; Bondarenko, I; Garin, AM; Brincat, S; Chow, L (J Clin Oncol., 2013)